136 related articles for article (PubMed ID: 32490681)
21. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
22. Simplified HCC-ART score for highly sensitive detection of small-sized and early-stage hepatocellular carcinoma in the widely used Okuda, CLIP, and BCLC staging systems.
Attallah AM; Omran MM; Attallah AA; Abdelrazek MA; Farid K; El-Dosoky I
Int J Clin Oncol; 2017 Apr; 22(2):332-339. PubMed ID: 27864623
[TBL] [Abstract][Full Text] [Related]
23. Midkine Increases Diagnostic Yield in AFP Negative and NASH-Related Hepatocellular Carcinoma.
Vongsuvanh R; van der Poorten D; Iseli T; Strasser SI; McCaughan GW; George J
PLoS One; 2016; 11(5):e0155800. PubMed ID: 27219517
[TBL] [Abstract][Full Text] [Related]
24. Glypican-3 level assessed by the enzyme-linked immunosorbent assay is inferior to alpha-fetoprotein level for hepatocellular carcinoma diagnosis.
Jeon Y; Jang ES; Choi YS; Kim JW; Jeong SH
Clin Mol Hepatol; 2016 Sep; 22(3):359-365. PubMed ID: 27729630
[TBL] [Abstract][Full Text] [Related]
25. Urinary transforming growth factor-beta 1 in relation to serum alpha-fetoprotein in hepatocellular carcinoma.
Tsai JF; Jeng JE; Chuang LY; Chang WY; Hsieh MY; Lin ZY; Tsai JH
Scand J Gastroenterol; 1997 Mar; 32(3):254-60. PubMed ID: 9085463
[TBL] [Abstract][Full Text] [Related]
26. Usefulness of AFP, AFP-L3, and PIVKA-II, and their combinations in diagnosing hepatocellular carcinoma.
Park SJ; Jang JY; Jeong SW; Cho YK; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Park S; Bang HI
Medicine (Baltimore); 2017 Mar; 96(11):e5811. PubMed ID: 28296720
[TBL] [Abstract][Full Text] [Related]
27. Differential expression and diagnostic significance of P53, MutS homologs 2, tropomyosin-4 in alpha-fetoprotein-negative hepatocellular carcinoma.
Gong X; Huang A
J Clin Lab Anal; 2020 Aug; 34(8):e23353. PubMed ID: 32363617
[TBL] [Abstract][Full Text] [Related]
28. Development and potential application of a simultaneous multiplex assay of Golgi protein 73 and alpha-fetoprotein for hepatocellular carcinoma diagnosis.
Xiao J; Long F; Peng T; Hu LB; Cai H; Chen R; Chen WL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3302-3310. PubMed ID: 31081083
[TBL] [Abstract][Full Text] [Related]
29. Performance of Alpha Fetoprotein in Combination with Alpha-1-acid Glycoprotein for Diagnosis of Hepatocellular Carcinoma Among Liver Cirrhosis Patients.
Gani RA; Suryamin M; Hasan I; Lesmana CR; Sanityoso A
Acta Med Indones; 2015 Jul; 47(3):216-22. PubMed ID: 26586387
[TBL] [Abstract][Full Text] [Related]
30. Development and application of a fluorescence protein microarray for detecting serum alpha-fetoprotein in patients with hepatocellular carcinoma.
Zhang A; Yin C; Wang Z; Zhang Y; Zhao Y; Li A; Sun H; Lin D; Li N
J Int Med Res; 2016 Dec; 44(6):1414-1423. PubMed ID: 27885040
[TBL] [Abstract][Full Text] [Related]
31. Comparison of diagnostic accuracy of Midkine and AFP for detecting hepatocellular carcinoma: a systematic review and meta-analysis.
Lu Q; Li J; Cao H; Lv C; Wang X; Cao S
Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32039435
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the Combined Application of AFP, AFP-L3%, and DCP for Hepatocellular Carcinoma Diagnosis: A Meta-analysis.
Wang X; Zhang Y; Yang N; He H; Tao X; Kou C; Jiang J
Biomed Res Int; 2020; 2020():5087643. PubMed ID: 33015170
[TBL] [Abstract][Full Text] [Related]
33. Clinical utility of simultaneous measurement of alpha-fetoprotein and des-γ-carboxy prothrombin for diagnosis of patients with hepatocellular carcinoma in China: A multi-center case-controlled study of 1,153 subjects.
Song P; Feng X; Inagaki Y; Song T; Zhang K; Wang Z; Zheng S; Ma K; Li Q; Kong D; Wu Q; Zhang T; Zhao X; Hasegawa K; Sugawara Y; Kokudo N; Tang W;
Biosci Trends; 2014 Oct; 8(5):266-73. PubMed ID: 25382443
[TBL] [Abstract][Full Text] [Related]
34. Combination of exosomes and circulating microRNAs may serve as a promising tumor marker complementary to alpha-fetoprotein for early-stage hepatocellular carcinoma diagnosis in rats.
Liu WH; Ren LN; Wang X; Wang T; Zhang N; Gao Y; Luo H; Navarro-Alvarez N; Tang LJ
J Cancer Res Clin Oncol; 2015 Oct; 141(10):1767-78. PubMed ID: 25724413
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic Value of Serum Biomarkers for Patients Undergoing Curative Resection with Non-B, Non-C Hepatocellular Carcinoma.
Li Y; Chen Y; Chen J
J Coll Physicians Surg Pak; 2020 Feb; 30(2):134-138. PubMed ID: 32036818
[TBL] [Abstract][Full Text] [Related]
36. Alpha-fetoprotein-L3 in hepatocellular carcinoma: a meta-analysis.
Yi X; Yu S; Bao Y
Clin Chim Acta; 2013 Oct; 425():212-20. PubMed ID: 23954771
[TBL] [Abstract][Full Text] [Related]
37. On-treatment alpha-fetoprotein is a specific tumor marker for hepatocellular carcinoma in patients with chronic hepatitis B receiving entecavir.
Wong GL; Chan HL; Tse YK; Chan HY; Tse CH; Lo AO; Wong VW
Hepatology; 2014 Mar; 59(3):986-95. PubMed ID: 24123097
[TBL] [Abstract][Full Text] [Related]
38. Five Novel Oncogenic Signatures Could Be Utilized as AFP-Related Diagnostic Biomarkers for Hepatocellular Carcinoma Based on Next-Generation Sequencing.
Yu Z; Wang R; Chen F; Wang J; Huang X
Dig Dis Sci; 2018 Apr; 63(4):945-957. PubMed ID: 29442275
[TBL] [Abstract][Full Text] [Related]
39. Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.
Liu X; Chi X; Gong Q; Gao L; Niu Y; Chi X; Cheng M; Si Y; Wang M; Zhong J; Niu J; Yang W
PLoS One; 2015; 10(5):e0127518. PubMed ID: 25996938
[TBL] [Abstract][Full Text] [Related]
40. A Logistic Regression Model for Noninvasive Prediction of AFP-Negative Hepatocellular Carcinoma.
Luo CL; Rong Y; Chen H; Zhang WW; Wu L; Wei D; Wei XQ; Mei LJ; Wang FB
Technol Cancer Res Treat; 2019 Jan; 18():1533033819846632. PubMed ID: 31106685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
